Suppr超能文献

门诊连续化疗输注方案中完全植入式静脉通路端口和便携式泵的评估。

Evaluation of a totally implanted venous access port and portable pump in a continuous chemotherapy infusion schedule on an outpatient basis.

作者信息

Greidanus J, de Vries E G, Nieweg M B, de Langen Z J, Willemse P H

机构信息

Department of Internal Medicine, University Hospital Groningen, The Netherlands.

出版信息

Eur J Cancer Clin Oncol. 1987 Nov;23(11):1653-7. doi: 10.1016/0277-5379(87)90445-7.

Abstract

In this study we evaluated the feasibility of a totally implanted vascular access port (VAP) and portable infusion pump for cytostatic drug administration on an outpatient basis, in a 21-day continuous infusion schedule with 4-epidoxorubicin (phase I and phase II study) and mitoxantrone (phase I study). Patients were instructed to dissolve their own drugs at home. Fifty patients were treated with 114 cycles (2394 infusion days). The complication rate was low. In one patient thrombosis of the subclavian and superior caval vein resulted in the termination of treatment. One patient developed pulmonary embolism during treatment. Needle dislocation was observed in two patients. No septicaemia and no irreversible catheter occlusion were seen. Pump functioning was efficient and pump arrest (9 X) never lasted longer than 24 h. We conclude that a VAP and portable pump are a safe and reliable route of administration for cytostatic drugs on an outpatient basis and that patients are capable of preparing their own drugs at home without increase of complications.

摘要

在本研究中,我们评估了完全植入式血管通路端口(VAP)和便携式输液泵用于门诊患者细胞毒性药物给药的可行性,给药方案为21天持续输注4-表阿霉素(I期和II期研究)和米托蒽醌(I期研究)。指导患者在家自行溶解药物。50例患者接受了114个周期(2394个输注日)的治疗。并发症发生率较低。1例患者锁骨下静脉和上腔静脉血栓形成导致治疗终止。1例患者在治疗期间发生肺栓塞。2例患者出现针头移位。未观察到败血症和不可逆的导管阻塞。泵功能良好,泵停止工作(9次)从未超过24小时。我们得出结论,VAP和便携式泵是门诊患者细胞毒性药物给药的安全可靠途径,患者能够在家自行准备药物而不会增加并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验